Table 1.
Baseline characteristics of the study participants.
| Placebo (n = 30) | Chromium (n = 30) | Magnesium (n = 30) | Chromium + Magnesium (n = 30) | |
|---|---|---|---|---|
| Age (years) | 50.89 ± 8.06 | 53.87 ± 8.73 | 52 ± 7.75 | 51 ± 9.05 |
| Gender, male (%) | 12 (40%) | 18 (60%) | 27 (90%) | 21 (70%) |
| BMI(kg/m2) | 23.67 ± 3.09 | 23.80 ± 1.54 | 24.37 ± 1.89 | 24.40 ± 1.80 |
| Fasting glucose (mmol/L) | 5.85 ± 0.50 | 5.85 ± 0.77 | 5.77 ± 0.98 | 5.77 ± 0.56 |
| 2 h glucose (mmol/L) | 9.28 ± 0.53 | 9.41 ± 0.79 | 9.45 ± 0.81 | 9.51 ± 1.03 |
| Fasting Insulin (uU/ml) | 12.40 ± 5.77 | 13.44 ± 8.35 | 13.99 ± 7.95 | 12.48 ± 8.75 |
| HOMA-IR | 3.27 ± 1.76 | 3.35 ± 2.70 | 3.00 ± 3.00 | 2.18 ± 1.67 |
| Triglyceride (mg/dl) | 2.15 ± 1.03 | 2.08 ± 0.66 | 2.11 ± 1.12 | 2.13 ± 0.79 |
| Total cholesterol (mg/dl) | 5.08 ± 0.89 | 5.11 ± 0.95 | 4.93 ± 0.76 | 5.12 ± 0.96 |
| LDL-cholesterol (mg/dl) | 3.21 ± 0.86 | 3.26 ± 0.82 | 3.42 ± 0.95 | 3.23 ± 1.31 |
| HDL-cholesterol (mg/dl) | 1.33 ± 0.32 | 1.33 ± 0.31 | 1.28 ± 0.34 | 1.21 ± 0.21 |
| Waist hip ratio | 0.88 ± 0.06 | 0.89 ± 0.06 | 0.89 ± 0.06 | 0.89 ± 0.05 |
| hsCRP (mg/L) | 2.43 ± 1.46 | 2.50 ± 1.49 | 2.42 ± 1.46 | 2.36 ± 1.13 |
| 8-iso-PGF2a (pg/ml) | 67.89 ± 11.03 | 66.71 ± 8.72 | 68.03 ± 6.88 | 67.51 ± 8.95 |
*Where applicable, values are expressed as Mean ± SEM and median and interquartile range. No significant difference was observed among the groups (p > .05).